iShares Genomics Immunology and Healthcare ETF
IDNA----
Portfolio
Oct 7, 2026- Stock99.67%
- Cash0.33%
Morningstar style box
Oct 7, 2026Current style: Mid Blend
Large
Mid
Small
12%
15%
0%
6%
25%
1%
8%
20%
12%
ValueBlendGrowth
Weight %50+25-4910-240-9
Top Holdings
Oct 7, 2026Top 10 Holdings Weight: 47.9%
| Name/code | Weight | Type | Industry | Style | Price | Change % | Market Cap |
|---|---|---|---|---|---|---|---|
| 11.90% | Equity | Health Care | Large Blend | — | — | — | |
| 6.46% | Equity | Health Care | Mid Blend | — | — | — | |
| 4.52% | Equity | Health Care | Small Growth | — | — | — | |
4  Genmab AS | 4.34% | — | — | — | — | — | — |
| 3.87% | Equity | Health Care | Mid Blend | — | — | — | |
6 Takeda Pharmaceutical Co Ltd | 3.41% | — | — | — | — | — | — |
| 3.40% | Equity | Health Care | Large Blend | — | — | — | |
| 3.38% | Equity | Health Care | Large Value | — | — | — | |
| 3.35% | Equity | Health Care | Large Value | — | — | — | |
| 3.31% | Equity | Health Care | Mid Blend | — | — | — |
